| |
CXCL9-11 Haplotypes
|
Association
|
p
|
|---|
|
rs10336
|
rs3921
|
rs4619915
|
Freq.
|
aOR (95% CI)
|
|---|
|
F ≥ 2 (≥7.1 kPa)
|
G
|
G
|
G
|
0.581
|
0.95 (0.70; 1.30)
|
0.760
|
| |
A
|
C
|
A
|
0.401
|
1.01 (0.74;1.39)
|
0.929
|
| |
A
|
G
|
G
|
0.011
|
2.50 (0.59;10.5)
|
0.198
|
|
F ≥ 3 (≥9.5 kPa)
|
G
|
G
|
G
|
0.581
|
0.97 (0.70;1.36)
|
0.868
|
| |
A
|
C
|
A
|
0.401
|
1.10 (0.78;1.54)
|
0.597
|
| |
A
|
G
|
G
|
0.011
|
0.32 (0.04;2.64)
|
0.226
|
|
F4 (≥12.5 kPa)
|
G
|
G
|
G
|
0.581
|
0.91 (0.62;1.34)
|
0.629
|
| |
A
|
C
|
A
|
0.401
|
1.12 (0.76;1.66)
|
0.557
|
| |
A
|
G
|
G
|
0.011
|
0.58 (0.07;4.85)
|
0.591
|
- Statistical: p values were calculated by multivariate logistic regression adjusted by the most important clinical and epidemiological characteristics
-
95% CI 95% of confidence interval, aOR adjusted odds ratio, p value level of significance, F ≥ 2 significant fibrosis, F ≥ 3 advance fibrosis, F4 cirrhosis, HCV-GT hepatitis C virus genotype, CXCL chemokine (C-X-C motif) ligand
